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• This work is funded by the National Institutes of Health through Grant R01 
AI 77706-01
– Immune System Biological Networks:  A Case Study in Improved Data 
Integration & Analysis
• Aim 1: Create an ontology-based representation of host-pathogen 
interactions, focusing on Staphylococcus aureus bacteremia.
• Aim 2: Empirically test the ability of the ontology-based representation 
created in Aim 1 to improve the analysis and interpretation of clinical 
data.
• Aim 3. Empirically test the impact of the ontology-based representation 
created in Aim 1 on understanding Staphylococcus aureus pathogenesis, 







































































I. Introduction to IDO
II. Resistance phenomena and their ontological 
representation
III. Case Study: The antibiotic resistance of MRSa
IV. Formalization into triples







































































Infectious Disease Ontology (IDO)
• An domain ontology extending BFO 
• An interoperable part of the OBO foundry.  
• Top-level IDO: A core upper ontology for the entire infectious 
disease domain
– At different biological scales
– From different disciplinary perspectives
– ~200 terms
• IDO-extensions: A family of reference ontologies for specific 
diseases and pathogens (e.g., Staph aureus, Malaria, 
Influenza…)







































































Dispositional view of disease
 disorder
(independent continuant part of bearer)
 disease course 
(a process aggregate in which disease is realized/manifested)
 physical basis of disease
(qualities inhering in the disorder)
 disease (disposition)









































































– Resistance of an individual to a disease
– Resistance of a tumor to a treatment
– Resistance of a pathogen to a drug
– Herd immunity of an organism population to a 
– Immunity of an individual to an infectious organism
– Resistance of certain bacteria to UV! 
http://edition.cnn.com/2009/TECH/science/03/17/india.bacteria/
• Resistance as a disposition 
– Different types of bearers at different biological scales






































































Resistance in existing 
terminologies
• [NCI Thesaurus: C19391] Resistance: Natural or acquired 
mechanisms, functions, activities, or processes exhibited by an 
organism to maintain immunity to, or to resist the effects of, 
an antagonistic agent, e.g., pathogenic microorganism, toxin, 
drug.
• Issues:
– Circular definition: uses ‘resist’ in definition for resistance!
– What is the type: mechanism? function? activity? process?
– Restricted to organism bearer 





































































Desiderata for IDO Representation
• BFO-compatible 
• Positive/active principle
– Don’t characterize resistance by what is not happening
– Use lacks wherever necessary 
• Non-proliferation of relations principle
– don’t propose a trivial relation resistant_to
– work with OBO RO and RO-proposed relations
• Correct granularity
– General enough to cover examples
– Specific enough to be useful
• Pragmatic Concerns: IDO/IDO-extension terms should mirror 
scientific interest in resistance types.
– Example: water-resistant walls are probably also lemonade-resistant, but we 






































































Resistance the quality vs 
Resistance the disposition
• Resistance disposition 
– possessed in virtue of internal physical 
arrangement of bearer
– not always manifested when borne
– realized in active processes at some physical scale
• Resistance quality 
– a sufficiently low susceptibility
Low susceptibility to x High susceptibility to x
threshold







































































Dispositions in BFO 2.0
• BFO Disposition
– BFO Capability: a disposition that enables its bearer to 
participate in certain processes.
• BFO Function: a capability which evolved in its bearer or whose 
bearer was designed to have the disposition. 
• Categorical Base/Ground is a BFO Quality
– A disposition at a macroscale is usually conferred on its 
bearer by qualities of parts at a microscale
• This is the utility of dispositions in reasoning








































































• Methicillin Resistant Staph aureus 
(MRSa)
– A type of Staph aureus 
characterized by resistance to 
methicillin (and other β-lactam 
antibiotics).
– As such, treatment decisions and 
public-health policies hinge on 
detecting MRSa
– Currently: A huge problem for 
healthcare providers…
Source: CDC’s PHIL
Our representation consists of:
1.A set of triples describing the 
entities involved in the resistance of 
MRSa to methicillin.
2.Logical inference rules a reasoner 
might use to justify the resistance.
Then use this formalization to inform 






































































The Rise and Antibiotic Resistance in Sa
Year Antibiotic Effectiveness
1943 Penicillin available
1947 First resistant strains reported
1960s Switch to methicillin
1961 Methicillin-resistant strain found in Cairo




2002 Vancomycin resistance reported



























































































































































1. bacteria is_a organism
2. MRSa is_a bacterium




5. Bacterial_cell_wall is_location_of PBP 
6. synthesis_of_peptidoglycan results_in_development_of
canonical bacterial_cell_wall
7. formation_of_bacterial_cell_wall is_a process
8. PBP2a is_a PBP
9. methicillin_PBP_binding_process is_a binding process that 
has_participants methicillin and PBP 
10. affinity_to_methicillin disposition_of some PBP to 
undergo a methicillin_PBP_binding_process that is 
realized in the presence of a methicillin.
11. methicillin_PBP_binding_process negatively_regulates
synthesis_of_peptidoglycan.
12. PBP2a lacks affinity_to_methicillin
13. mecA is_a gene
14. MRSa has_part mecA
15. mecA generically_specifies PBP2a_production
16. PBP2a_production results_in_formation_of PBP2a
Inferences
• (IR1) x is_a y & y is_a z → x is_a z
• (IR2) x has_part y & y has_part z → x has_part z
• (D1) MRSa is_a organism 
• (IR3) o is_a organism & g is_a gene & o has_part g & 
g generically_specifies proc & 
proc results_in_formation_of prod & 
o has_part locp &  locp is_location_of prod) →
o has_part prod located_in locp
• (D2) MRSa has_part PBP2a located_in bacterial_cell_wall 
• (IR4) p lacks disposition to undergo proc1
realized in situation s
& proc1 negatively_regulates proc2 & proc2
has_participant p →
In situation s, p participates_in proc2
• (D3) In the presence of methicillin, PBP2a participates_in
synthesis_of_peptidoglycan.
• (IR5) In situation s, p1 participates_in proc & 
p1 located_in p2 & o has_part p2 →
proc unfolds_in o in situation s.
• (D4) synthesis_of_peptidoglycan unfolds_in MRSa in the 
presence of methicillin.
• (IR6) In situation s, proc unfolds_in o & 
proc results_in_development_of p →
p part_of o in situation s
• (D5) Canonical bacterial_cell_wall part_of MRSa in the 
presence of methicillin.
16 triples + 6 inf rence rules + 5 derived triples



































































































































































































































• IDO: Protective resistance is a disposition that 
inheres in an material entity x by virtue of the 
fact that the entity has a part (e.g., a gene 
product), which itself has a disposition to 
ensure a physiologic response of a certain 
degree to a potentially damaging entity y, or 
to prevent the completion of some process 
caused by y, thereby protecting x from or 
mitigating the damaging effects of y.
Allows for both organisms 
and tumors
with the capability to damage
Usually a 
function, but 
may be just a 
capability
e.g., CCR5 mutation prevents the completion 







































































• Resistance is a very important biological phenomenon…
– Guiding treatment decisions
– Public health policy
• and a very general phenomenon…
– Multi-scale (gene, cell, organ, organism, population)
– Multi-discipline (clinical, biological, epidemiological)
• Whose representation in an ontology is non-trivial
– Even a particular instance of resistance requires many triples for 
description and inference.
– Needs further analysis of lacking a disposition (e.g., lacking the affinity 
to methicillin).
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